series is mainly divided into Deep, Sub-Q, and Fine. Deep (1.1ml, 24mg/ml) suits mid-layer filling, its effect lasts 12–18 months, and it costs about 500–800 USD; Sub-Q (26mg/ml) is used for chin shaping, lasts 12–24 months, and costs about 600–1000 USD; Fine (20mg/ml) suits fine line correction, lasts 8–12 months, and costs about 200–400 USD.
Revolax Deep
According to data, the market share of Revolax Deep in the global hyaluronic acid market has reached 22%, and its sales in Asia show an annual growth rate of 18%. Revolax Deep comes in a volume of 1.1ml per unit, which is a 10% increase compared to the standard 1ml hyaluronic acid specification. The single-unit cost of Revolax Deep in Asia is about 300 USD to 500 USD, while in the European market it is 400 EUR to 600 EUR. In a consumer survey in the beauty industry, over 72% of respondents choose Revolax Deep because of its balance between price and effect. Revolax Deep uses a monophase cross-linking technique, and the cross-linking degree of the hyaluronic acid molecules exceeds 90%. In laboratory simulation tests, the product’s metabolic cycle in simulated body fluids can reach 14–16 months, which makes its durability more outstanding compared to the common 8–12 months products on the market. Revolax Deep contains 0.3% lidocaine. According to clinical statistics from a well-known Korean beauty institution, about 85% of customers using this product report a pain score below 2 on a 10-point scale, while with other non-anesthetic hyaluronic acid products, the score usually ranges from 4 to 6. Doctors usually recommend a single injection dosage of 1–2 ml, and for clients undergoing full-face improvement, the total dosage can reach 5–6 ml in multiple sessions. According to feedback from the beauty industry, about 92% of users express satisfaction with the effect after the first injection and plan to have follow-up maintenance within 12–18 months. According to 2022 clinical data covering 10,000 injections, the adverse reaction rate is only 0.15%. Symptoms usually subside within 48–72 hours. Data from a British beauty clinic shows that among 200 clients who underwent nose bridge and chin shaping using Revolax Deep, 97% report a natural effect. Over 80% of the clients notice an improvement in skin condition on the third day after the procedure.
Revolax Sub-Q
Each unit of Revolax Sub-Q has a volume of 1.1ml. Statistics show that worldwide, the usage of Revolax Sub-Q accounts for 35% of the total sales of the Revolax series. Revolax Sub-Q has a polymer density of 20 mg/ml. In chin shaping, a single injection usually requires only 1–1.5 ml to significantly improve contour lines, and the average maintenance time is between 12–18 months. Revolax Sub-Q has a longer metabolic cycle, with a residual rate of up to 35%, while the industry average is around 25%. The market pricing of Revolax Sub-Q is generally 400–600 USD per unit. In Korea, the product’s price averages about 350 USD, while in the European and North American markets, the cost per unit can reach over 500 USD. According to statistics released by the Korean Association of Aesthetic Medicine, in the application of deep filling, Revolax Sub-Q has an adverse reaction rate of only 0.12%, far lower than the industry average of 0.2%. Within 7–10 days after injection, over 90% of customers state that the filled area is smooth and natural. In chin filling, the single injection dosage is usually 1–2 ml, while in temple shaping, doctors recommend injecting 0.8–1 ml per side to achieve symmetrical results. In complex full-face filling schemes, the usage of Revolax Sub-Q accounts for about 60% of the total injection volume. Research shows that the monophase cross-linking technique can reduce the metabolic rate by 20% under simulated human body temperature. According to a European survey report covering 500 clients, over 93% of users feel satisfied with the post-operative effect. Among doctors, over 80% of respondents say they are more willing to recommend the product.
Revolax Fine
Revolax Fine has a molecular density of 20 mg/ml. Statistics show that sales of Revolax Fine account for 25% of the entire Revolax series in the global market. The packaging specification of Revolax Fine is 1.1ml, which offers a 10% extra filler compared to most products on the market with a capacity of 1ml. In the treatment of tear troughs, mouth corners, and forehead fine lines, the single injection dosage is usually 0.5–1 ml. According to data from the Korean Beauty Association, the customer satisfaction rate for superficial filling using Revolax Fine reaches 89%. The market pricing of Revolax Fine is 250–400 USD per unit. In the Asian market, the average price is 300 USD, while in Europe and North America, the price range is about 350–450 USD. In a laboratory study, Revolax Fine shows a slower degradation rate in a simulated human environment, with an average metabolic cycle of 8–12 months. Compared to the average 6–9 months effect of traditional hyaluronic acid products, the maintenance time of Revolax Fine has more advantages. Revolax Fine contains 0.3% lidocaine. In a questionnaire survey including 500 users, over 92% of respondents say the injection experience is comfortable, with a pain score of only 1–2 on a 10-point scale. In tear trough filling, the single-side injection dosage of Revolax Fine is usually 0.3–0.5 ml, while in crow’s feet repair, the dosage per side is only about 0.2 ml. According to statistics from the European and American markets, tear trough filling is the main application scenario of Revolax Fine, accounting for over 60% of the total usage. According to statistics from the British Association of Aesthetic Medicine, the adverse reaction rate of Revolax Fine is only 0.1%. Symptoms usually subside naturally within 24–48 hours. The annual sales growth rate of Revolax Fine is 15%. In the Asian market, its sales grew by 18% year-on-year in 2023. The operation time for Revolax Fine is usually 20–30 minutes, saving about 30% of the time compared to deep fillers.
Application Areas
In the global market, the application distribution of the Revolax series products shows that about 60% is used for facial shaping, 25% for anti-aging, and 15% for local fine line correction. Data shows that in the Asian market, the demand for a high and prominent nose bridge is higher, accounting for 70% of the total demand for nose bridge shaping. When using Revolax filler for nose bridge shaping, the single injection dosage usually is 0.5 to 1 ml, the average cost is 300 to 600 USD, and the effect lasts for 12 to 18 months. In the European and American markets, about 35% of facial filling demand concentrates on the chin area. The single injection dosage for is 1 to 2 ml, and the total cost is about 600 to 1000 USD. According to a survey covering 500 beauty seekers, 94% of users feel satisfied with the improvement of the chin contour after injection. Global tear trough filling demand accounts for over 40% of the total demand for superficial filling, with a single injection dosage of 0.3 to 0.5 ml, and the price range is 200 to 400 USD. In a statistic involving 1000 customers, over 90% of users think that after using Revolax Fine to repair tear troughs, the overall face looks younger. Data shows that about 45% of facial filling demand relates to nasolabial fold improvement. The single injection dosage is 1 to 2 ml, the cost is about 500 to 800 USD, and in cases of nasolabial fold repair using Revolax Deep, 92% of users see significant effects within two weeks, with the duration lasting up to 18 months. The single injection dosage for malar (apple) muscle is 0.8 to 1.5 ml, and the cost is about 400 to 700 USD. According to a study, the satisfaction rate after malar filling is as high as 88%. Data shows that about 30% of forehead filling demand comes from the Asian market. The single injection dosage is 1 to 2 ml, and the price range is 600 to 900 USD. Statistics show that temple filling demand accounts for about 20% of full-face filling, with a single injection dosage of 0.5 to 1.5 ml, and the cost is 400 to 800 USD. In a study covering 300 cases of temple filling, 98% of users state that the temple depression improves significantly after injection. The single injection dosage for crow’s feet repair is 0.2 to 0.5 ml, and the price is 200 to 400 USD. According to a report from the European Beauty Association, the demand for crow’s feet repair is particularly prominent in the 30 to 45 age group, accounting for 60%. After using Revolax Fine, the effect on crow’s feet lasts on average 8 to 12 months. The single injection dosage for the nasal tip is 0.2 to 0.5 ml, and the cost is 200 to 500 USD. Data shows that Asian customers account for 40% of the total nasal shaping demand in terms of nasal tip lifting. The total dosage for comprehensive shaping usually is 6 to 10 ml, and the cost ranges from 3000 to 6000 USD. In a survey covering 2000 users, over 95% of users state they are satisfied with the comprehensive shaping effect.
Density Differences
Revolax Fine has a molecular density of 20 mg/ml. According to market data, about 45% of consumers choose Revolax Fine for tear trough repair. The single injection dosage usually is 0.3 to 0.5 ml, the total cost is about 200 to 400 USD, and the effect lasts 8 to 12 months. has a molecular density of 24 mg/ml. Statistics show that Revolax Deep occupies 35% of the facial filling market share. The single injection dosage for nasolabial fold filling is 1 to 2 ml, the cost is 500 to 800 USD, and the effect lasts 12 to 18 months. Revolax Sub-Q has a molecular density of 26 mg/ml. In chin shaping, the single injection dosage is 1 to 2 ml, and the total cost is about 600 to 1000 USD. According to a survey covering 2000 beauty seekers, 95% of users are highly satisfied with the shaping effect of Sub-Q. Revolax Fine has a metabolic cycle that usually is 8 to 12 months, while Revolax Deep and Sub-Q last 12 to 18 months. In a clinical study covering 5000 injections, the adverse reaction rate of the Revolax series is only 0.1%, among which the higher density Sub-Q accounts for less than 0.03%. According to a report from the European Beauty Association, 80% of doctors highly recognize the injection performance of Deep and Sub-Q. In the 25 to 35 age group, about 60% of consumers choose the low-density Revolax Fine, while in the 35 to 50 age group, the medium-density Revolax Deep accounts for over 50%. For consumers over 50, the usage rate of the high-density Revolax Sub-Q reaches 70%.
Longevity Results
According to research in the global beauty market, the effects of the Revolax series products last on average 8 to 18 months. In all injection cases, over 90% of users express satisfaction with the durability of the effects. has an average effect duration of 8 to 12 months. Statistics show that about 65% of tear trough repair customers still see a significant filling effect in the 10th month after injection, while in crow’s feet repair, this time shortens to about 8 months. Revolax Deep has a metabolic cycle of 12 to 18 months. In a study of 1000 cases of nasolabial fold filling, the effect after using Revolax Deep remains stable at 6 months post-procedure, and over 80% of users still feel satisfied with the results after 18 months. Revolax Sub-Q has a metabolic cycle of 12 to 24 months. In chin shaping, over 75% of users still feel a significant effect at 18 months post-procedure, while the durability of forehead filling usually is 12 to 15 months. The single injection cost of Revolax Deep is about 500 to 800 USD, and based on its 18-month duration, the monthly cost is only 30 to 45 USD. Compared with many hyaluronic acid products on the market that last only 6 to 12 months, Revolax has higher economic efficiency. For younger people with faster metabolism, the metabolic cycle may shorten by 10% to 20%. In a survey of 500 young users, the average duration of Revolax Fine in users aged 25 to 35 is 8 to 10 months, while in users over 35, this time extends to 10 to 12 months. In a laboratory simulation study, the degradation rate of Revolax Deep and Sub-Q at 37°C is 20% slower than the industry average. According to a report from the Korean Association of Aesthetic Medicine, the dissolution efficiency of Revolax products reaches 98%, while the industry average is 90%.
Suitability Tips
According to data from the International Beauty Association, over 80% of customers using hyaluronic acid fillers find that their needs do not completely match their initial choices after consultation. Revolax Fine has a molecular density of 20 mg/ml, the single injection dosage usually is 0.3 to 0.5 ml, and the cost is 200 to 400 USD. Research shows that about 65% of users under 30 choose Revolax Fine, and the effect lasts 8 to 12 months. Revolax Deep has a molecular density of 24 mg/ml, and suits mid-layer filling. Data shows that among users aged 35 to 50, the proportion of those using Revolax Deep for nasolabial fold filling accounts for 45% of the total demand, the single injection cost is about 500 to 800 USD, and the effect lasts 12 to 18 months. Revolax Sub-Q has a molecular density of 26 mg/ml, the single injection dosage for the chin is 1 to 2 ml, and the total cost is 600 to 1000 USD. In a survey covering 1000 beauty seekers, 92% of users are highly satisfied with the shaping effect of Sub-Q. In the 25 to 35 age group, about 70% choose Revolax Fine for tear trough and fine line repair, while in the 35 to 50 age group, the usage rate of Revolax Deep reaches 50%. For customers over 50, 60% prefer to choose Revolax Sub-Q. The price range of the Revolax series spans from 200 USD to 1000 USD. According to statistics, among customers choosing Sub-Q, 80% state that the long-term effect of a single injection makes the overall cost more competitive. In a clinical trial covering 500 cases of injection, the postoperative satisfaction rate of customers who choose the correct type reaches 95%, far higher than the 75% of those who choose the wrong product. Research shows that in cases requiring adjustment or repair, hyaluronidase dissolves Revolax